This company has been marked as potentially delisted and may not be actively trading. Cesca Therapeutics (KOOL) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsDividendOwnershipTrendsBuy This Stock KOOL vs. KEQU, THMO, ANIX, IVCP, MGRM, ORMP, MGNX, VOR, QIPT, and EXOZShould you be buying Cesca Therapeutics stock or one of its competitors? The main competitors of Cesca Therapeutics include Kewaunee Scientific (KEQU), ThermoGenesis (THMO), Anixa Biosciences (ANIX), Swiftmerge Acquisition (IVCP), Monogram Orthopaedics (MGRM), Oramed Pharmaceuticals (ORMP), MacroGenics (MGNX), Vor Biopharma (VOR), Quipt Home Medical (QIPT), and Exozymes (EXOZ). Cesca Therapeutics vs. Kewaunee Scientific ThermoGenesis Anixa Biosciences Swiftmerge Acquisition Monogram Orthopaedics Oramed Pharmaceuticals MacroGenics Vor Biopharma Quipt Home Medical Exozymes Kewaunee Scientific (NASDAQ:KEQU) and Cesca Therapeutics (NASDAQ:KOOL) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, community ranking, risk, valuation, profitability, dividends, analyst recommendations, media sentiment and institutional ownership. Which has more volatility & risk, KEQU or KOOL? Kewaunee Scientific has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500. Comparatively, Cesca Therapeutics has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500. Is KEQU or KOOL more profitable? Kewaunee Scientific has a net margin of 9.39% compared to Cesca Therapeutics' net margin of -98.84%. Kewaunee Scientific's return on equity of 25.83% beat Cesca Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Kewaunee Scientific9.39% 25.83% 10.75% Cesca Therapeutics -98.84%-77.30%-37.75% Does the media refer more to KEQU or KOOL? In the previous week, Kewaunee Scientific had 1 more articles in the media than Cesca Therapeutics. MarketBeat recorded 1 mentions for Kewaunee Scientific and 0 mentions for Cesca Therapeutics. Kewaunee Scientific's average media sentiment score of 1.79 beat Cesca Therapeutics' score of 0.00 indicating that Kewaunee Scientific is being referred to more favorably in the media. Company Overall Sentiment Kewaunee Scientific Very Positive Cesca Therapeutics Neutral Which has preferable valuation and earnings, KEQU or KOOL? Kewaunee Scientific has higher revenue and earnings than Cesca Therapeutics. Cesca Therapeutics is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKewaunee Scientific$220.03M0.41$18.75M$5.915.29Cesca Therapeutics$9.67M2.62-$39.72M-$3.60-2.91 Does the MarketBeat Community believe in KEQU or KOOL? Cesca Therapeutics received 125 more outperform votes than Kewaunee Scientific when rated by MarketBeat users. Likewise, 70.45% of users gave Cesca Therapeutics an outperform vote while only 67.62% of users gave Kewaunee Scientific an outperform vote. CompanyUnderperformOutperformKewaunee ScientificOutperform Votes14267.62% Underperform Votes6832.38% Cesca TherapeuticsOutperform Votes26770.45% Underperform Votes11229.55% Do institutionals & insiders hold more shares of KEQU or KOOL? 32.7% of Kewaunee Scientific shares are owned by institutional investors. Comparatively, 3.1% of Cesca Therapeutics shares are owned by institutional investors. 14.2% of Kewaunee Scientific shares are owned by insiders. Comparatively, 68.9% of Cesca Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryKewaunee Scientific beats Cesca Therapeutics on 10 of the 15 factors compared between the two stocks. Get Cesca Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KOOL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KOOL vs. The Competition Export to ExcelMetricCesca TherapeuticsLaboratory Apparatus & Furniture IndustryMedical SectorNASDAQ ExchangeMarket Cap$25.30M$89.25M$5.54B$7.99BDividend Yield0.50%N/A5.36%4.22%P/E Ratio-2.914.9522.6818.92Price / Sales2.620.41404.51107.03Price / CashN/A45.3038.1834.62Price / Book3.372.306.764.32Net Income-$39.72M$18.75M$3.22B$248.18M Cesca Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KOOLCesca TherapeuticsN/A$10.47+1.3%N/A+6.5%$25.30M$9.67M-2.9153KEQUKewaunee Scientific2.6651 of 5 stars$33.49+0.2%N/A-10.5%$91.02M$220.03M5.05890Positive NewsTHMOThermoGenesisN/A$0.00-85.7%N/AN/A$1,000.00$9.61M0.0040Gap DownANIXAnixa Biosciences1.5993 of 5 stars$2.83+3.9%$9.00+218.6%-5.4%$90.96M$210,000.00-7.245IVCPSwiftmerge AcquisitionN/A$13.19-21.6%N/A+5.8%$90.22MN/A-659.502,021Gap DownMGRMMonogram Orthopaedics2.0463 of 5 stars$2.57-4.8%$5.40+110.1%+49.0%$89.71M$364,999.00-5.4128Upcoming EarningsORMPOramed Pharmaceuticals0.87 of 5 stars$2.20+2.1%N/A-1.3%$89.67M$1.34M19.9510Upcoming EarningsPositive NewsGap DownMGNXMacroGenics3.9589 of 5 stars$1.40+10.7%$7.38+428.7%-88.8%$88.77M$148.34M-0.89430Upcoming EarningsVORVor Biopharma2.5521 of 5 stars$0.71+3.1%$8.86+1,151.0%-63.3%$88.52MN/A-0.43140Positive NewsQIPTQuipt Home Medical2.0755 of 5 stars$2.05+2.0%$6.25+204.9%-45.1%$88.34M$244.72M-12.06800Upcoming EarningsGap UpEXOZExozymesN/A$10.47-3.4%N/AN/A$87.61MN/A0.0029 Related Companies and Tools Related Companies KEQU Alternatives THMO Alternatives ANIX Alternatives IVCP Alternatives MGRM Alternatives ORMP Alternatives MGNX Alternatives VOR Alternatives QIPT Alternatives EXOZ Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KOOL) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cesca Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cesca Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KOOL Stock Free KOOL Stock Alerts